A tonsil organoid model reveals Epstein-Barr virus infected germinal center B cell states during primary infection
Mahina Tabassum MituliD, Yizhe SuniD, Timothy B. YatesiD, Suhas SureshchandraiD, Jenna M. KastenschmidtiD, Andrew M. SorniD, Zachary W. WagoneriD, Erika M. JoloyaiD, A. NairiD, Allyssa L. DaughertyiD, Naresha SaligramaiD, Gurpreet Ahuja, Qiu ZhongiD, Douglas Trask, Carmy R. ForneyiD, Rui GuoiD, Matthew T. WeirauchiD, Leah Claire KottyaniD, Benjamin E. GewurziD, Lisa E. WagariD
Abstract
Epstein-Barr virus (EBV) colonizes secondary lymphoid tissues to establish persistent infection and is strongly associated with malignancy and autoimmunity. Our understanding of EBV infection biology is hindered by a lack of models that capture infected B cell activity in the lymphoid tissue microenvironment. We therefore developed an EBV human tonsil organoid model to evaluate key B cell states and antiviral responses, including after primary infection. EBV promoted B cell differentiation into germinal center (GC)-like phenotypes and transcriptomic analyses highlighted numerous B cell transcriptional programs unique to EBV-infected cells. B cell receptor repertoire analysis revealed that most EBV-infected B cells underwent class switching but only rarely participated in somatic hypermutation. CD4 T cells, highly activated by organoid infection, limited EBV+ B cell outgrowth. Our findings demonstrate human tonsil organoids as a physiologically relevant model to investigate key aspects of EBV immunity and pathogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 43%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The primary and secondary immune response to Epstein-Barr virus infection of human tonsil organoids
Álvaro F. García-Jiménez, Luis Ignacio González-Granado, … Hugh T. Reyburn·bioRxiv·Jan 16, 2026
- EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND TREG-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
Leena Yoon, Lauren N. MacMullen, … Paul M. Lieberman·bioRxiv·Nov 20, 2025
- A high-resolution, unbiased analysis of the cellular immune response to Epstein-Barr virus
Álvaro F. García-Jiménez, Arianna Picozzi, … Hugh T. Reyburn·bioRxiv·Oct 9, 2025
- Epstein-Barr virus reprograms human B-lymphocytes immediately in the pre-latent phase of infection
P. Mrozek-Gorska, A. Buschle, … W. Hammerschmidt·bioRxiv·Dec 31, 2018
- The first days in the life of naïve human B-lymphocytes infected with Epstein-Barr virus
D. Pich, P. Mrozek-Gorska, … W. Hammerschmidt·mBioPeer-reviewed·Oct 29, 2019
- Epstein Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues
D. Kirchmeier, Y. Deng, … C. Munz·bioRxiv·Nov 24, 2023